Correction: Mcl-1 confers protection of Her2-positive breast cancer cells to hypoxia: therapeutic implications

Affiliations

• ¹ Department of Medical Oncology, National Center for Tumor Diseases (NCT), University of Heidelberg, Im Neuenheimer Feld #460, 69120, Heidelberg, Germany.
• ² Department of Pharmacology and Therapy, Faculty of Medicine, Universitas Padjadjaran, Jl. Eijkman 38, Bandung, 02215, Indonesia.
• ³ Dana-Farber Cancer Institute, 450 Brookline Avenue, Boston, MA, 02215, USA.
• ⁴ Eutropics, Inc., 767C Concord Avenue, Cambridge, MA, 02138, USA.
• ⁵ German Cancer Research Center (DKFZ), Im Neuenheimer Feld 460, 69120, Heidelberg, Germany.
• ⁶ St. Jude Children's Research Hospital, 262 Danny Thomas Place, Memphis, TN, 38105, USA.
• ⁷ Department of Medical Oncology, National Center for Tumor Diseases (NCT), University of Heidelberg, Im Neuenheimer Feld #460, 69120, Heidelberg, Germany. klaus.podar@krems.lknoe.at.